News From The Pharmaceutical Processing Industry: Summer 2017
Here’s a roundup of news and trends in the pharmaceutical manufacturing industry, gleaned from various industry publications:
Eric Resnick, Vice President and Chief Technology Officer, West Pharmaceutical Services, Inc., discusses how the introduction of biologic therapies has forced drug delivery manufacturers to take a more analytical approach to process scale-up.
A roundtable of bio/pharma expets – Guillaume Tremintin of Bruker Daltonics; Lisa Newey-Keane of Malvern Instruments; Gurmil Gendeh of Shimadzu; Kyle D’Silva and Simon Cubbon of Thermo Fisher Scientific; and Geofrey Wyatt of Wyatt Technology Corporation – discuss how advances in analytical testing tools are solving the challenges of drug development and manufacture.
Safety issues can pop up in unexpected ways when scaling up from small investigatory or pilot runs to full-scale production runs. This article looks at some of the possible danger points in chemical production scale-up.
Improvements in pharmaceutical manufacturing equipment are often overlooked. Advances in automation, process control, safety, and connected systems warrant additional attention. This article explores some of the breakthroughs in continuous solid-dosage manufacturing.
With an eye toward the future International Society for Pharmaceutical Engineering (ISPE) board chair Mike Arnold discusses challenges to the rise of personalized medicine.